Document Detail

Heart failure in acute ischemic stroke.
MedLine Citation:
PMID:  21804779     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Heart failure (HF) is a complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. Due to the aging of the population it has become a growing public health problem in recent decades. Diagnosis of HF is clinical and there is no diagnostic test, although some basic complementary testing should be performed in all patients. Depending on the ejection fraction (EF), the syndrome is classified as HF with low EF or HF with normal EF (HFNEF). Although prognosis in HF is poor, HFNEF seems to be more benign. HF and ischemic stroke (IS) share vascular risk factors such as age, hypertension, diabetes mellitus, coronary artery disease and atrial fibrillation. Persons with HF have higher incidence of IS, varying from 1.7% to 10.4% per year across various cohort studies. The stroke rate increases with length of follow-up. Reduced EF, independent of severity, is associated with higher risk of stroke. Left ventricular mass and geometry are also related with stroke incidence, with concentric hypertrophy carrying the greatest risk. In HF with low EF, the stroke mechanism may be embolism, cerebral hypoperfusion or both, whereas in HFNEF the mechanism is more typically associated with chronic endothelial damage of the small vessels. Stroke in patients with HF is more severe and is associated with a higher rate of recurrence, dependency, and short term and long term mortality. Cardiac morbidity and mortality is also high in these patients. Acute stroke treatment in HF includes all the current therapeutic options to more carefully control blood pressure. For secondary prevention, optimal control of all vascular risk factors is essential. Antithrombotic therapy is mandatory, although the choice of a platelet inhibitor or anticoagulant drug depends on the cardiac disease. Trials are ongoing to evaluate anticoagulant therapy for prevention of embolism in patients with low EF who are at sinus rhythm.
Elisa Cuadrado-Godia; Angel Ois; Jaume Roquer
Related Documents :
11641999 - Care of acute myocardial infarction in oklahoma: an update from the cooperative cardiov...
2470929 - Direct formation of angiotensin ii without renin or converting enzyme in the ischemic d...
22356569 - Lactate clearance in cardiogenic shock following st elevation myocardial infarction: a ...
22889589 - Quantitative first pass perfusion in cardiovascular magnetic resonance for determinatio...
11381289 - Why were the results of the heart outcomes prevention evaluation (hope) trial so astoun...
22370689 - Ventricular fibrillation in an ambulatory patient supported by a left ventricular assis...
8798129 - Recurrent carotid disease: will stents be an alternative to surgery?
2945419 - Morphology of the coronary arteries after combined thrombolysis and percutaneous transl...
9583449 - Recovery from complete atrioventricular block caused by idiopathic giant cell myocardit...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reviews     Volume:  6     ISSN:  1875-6557     ISO Abbreviation:  Curr Cardiol Rev     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2011-08-01     Completed Date:  2011-11-10     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101261935     Medline TA:  Curr Cardiol Rev     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  202-13     Citation Subset:  -    
Neurology Department, Hospital Universitari del Mar. Program on Research on Inflammatory and Cardiovascular Disorders, IMIM, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Blood biomarkers in cardioembolic stroke.
Next Document:  Cerebrovascular complications after heart transplantation.